Search - tctmd.com

Displaying 901 - 920 of 1167

Sort: Relevancy | Date

News Daily News

A-fib Common After Aortic Valve Replacement

Jason Kahn

January 30, 2014

News Industry News

Medtronic CoreValve® System Obtains Early FDA Approval

January 16, 2014

News Daily News

FFR Values for Intermediate Lesions Affected by Exaggerated Adenosine Response

January 15, 2014

News Daily News

La Comisurotomía Mitral Percutánea es Efectiva incluso en Válvulas Calcificadas

January 15, 2014

News Industry News

Edwards to Begin U.S. Trial of SAPIEN 3 Valve for Intermediate Risk Patients

January 12, 2014

News Daily News

TAVR早期结果与PARTNER研究结果相似，但并发症更少

Jason Kahn

January 01, 2014

News Daily News

Poststent Dilation in Carotid Stenting Linked to Hemodynamic Depression

January 01, 2014

News Daily News

PARTNER: Bleeding More Prevalent, Dangerous with Surgery vs. TAVR

Yael L. Maxwell

January 01, 2014

News Daily News

Los Resultados Iniciales TAVR son Equiparables a los Resultados PARTNER, aunque con Menos Complicaciones

Jason Kahn

January 01, 2014

News Daily News

Early TAVR Results Match PARTNER Outcomes, But With Fewer Complications

Jason Kahn

January 01, 2014

News Daily News

Anemia Present in More than Half of TAVR Patients, Raises Long-term Mortality

Jason Kahn

January 01, 2014

News Daily News

Groups Outline Key Issues for Dissemination of Transcatheter Mitral Valve Therapies

December 02, 2013

News Conference News AHA 2013

AHA 2013: Mix of Positive, Negative Trials Help Guide Interventional Practice

November 24, 2013

News Conference News TCT 2013

TAVR a Viable Option for Intermediate-Risk Patients

November 05, 2013

News Conference News TCT 2013

Second-Generation TAVR Device Overcomes Issues of Current Valves

October 31, 2013

News Industry News

Second Generation Transcatheter Aortic Valve Shown to Successfully Address Complications of TAVR

October 31, 2013

News Industry News

BOSTON SCIENTIFIC LOTUS™ VALVE SYSTEM MEETS

October 31, 2013

News Conference News TCT 2013

Two Trials to Assess TAVR in Moderate-Risk Patients

October 30, 2013

News Conference News TCT 2013

Innovation in Intervention: Perspectives from Industry

October 30, 2013

News Industry News

St. Jude Medical Reports Positive Clinical Outcomes from Portico Heart Valve Study

October 29, 2013

Advertisement

A-fib Common After Aortic Valve Replacement

Medtronic CoreValve® System Obtains Early FDA Approval

FFR Values for Intermediate Lesions Affected by Exaggerated Adenosine Response

La Comisurotomía Mitral Percutánea es Efectiva incluso en Válvulas Calcificadas

Edwards to Begin U.S. Trial of SAPIEN 3 Valve for Intermediate Risk Patients

TAVR早期结果与PARTNER研究结果相似，但并发症更少

Poststent Dilation in Carotid Stenting Linked to Hemodynamic Depression

PARTNER: Bleeding More Prevalent, Dangerous with Surgery vs. TAVR

Los Resultados Iniciales TAVR son Equiparables a los Resultados PARTNER, aunque con Menos Complicaciones

Early TAVR Results Match PARTNER Outcomes, But With Fewer Complications

Anemia Present in More than Half of TAVR Patients, Raises Long-term Mortality

Groups Outline Key Issues for Dissemination of Transcatheter Mitral Valve Therapies

AHA 2013: Mix of Positive, Negative Trials Help Guide Interventional Practice

TAVR a Viable Option for Intermediate-Risk Patients

Second-Generation TAVR Device Overcomes Issues of Current Valves

Second Generation Transcatheter Aortic Valve Shown to Successfully Address Complications of TAVR

BOSTON SCIENTIFIC LOTUS™ VALVE SYSTEM MEETS

Two Trials to Assess TAVR in Moderate-Risk Patients

Innovation in Intervention: Perspectives from Industry

St. Jude Medical Reports Positive Clinical Outcomes from Portico Heart Valve Study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content